Once-daily intravenous busulfan with therapeutic drug monitoring compared to conventional oral busulfan improves survival and engraftment in children undergoing allogeneic stem cell transplantation.

Imke H Bartelink; Robbert G M Bredius; Tessa T Ververs; Martine F Raphael; Charlotte van Kesteren; Marc Bierings; Carin M A Rademaker; J den Hartigh; Cuno S P M Uiterwaal; Juliette Zwaveling

doi:10.1016/j.bbmt.2007.09.015

Once-daily intravenous busulfan with therapeutic drug monitoring compared to conventional oral busulfan improves survival and engraftment in children undergoing allogeneic stem cell transplantation.

Identifier:nobleid.org/w1/20260515/ECCDF23E

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/ECCDF23E.svg?ark=w1%2F20260515%2FECCDF23E)](https://nobleid.org/work/w1/20260515/ECCDF23E)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Charlotte van Kesteren

Claim authorship of this work

Once-daily intravenous busulfan with therapeutic drug monitoring compared to conventional oral busulfan improves survival and engraftment in children undergoing allogeneic stem cell transplantation.

Identifier:nobleid.org/w1/20260515/ECCDF23E

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/ECCDF23E.svg?ark=w1%2F20260515%2FECCDF23E)](https://nobleid.org/work/w1/20260515/ECCDF23E)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Charlotte van Kesteren

Claim authorship of this work